Stroke

ACC 24 Late-Breaker Discussion: The AEGIS-II Trial

Harriette Van Spall, Michael C Gibson,

Watch time: 14m 7s
AHA ISC 24: ZODIAC: Zero Degree Head Positioning in Acute Stroke

Anne Alexandrov,

Watch time: 11m 16s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
UK Perspective on Cerebral Embolic Protection

Sam Dawkins,

Watch time: 2m 42s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
Radcliffe & CardioNerds @AHA22: The PREVENT-HD Randomized Clinical Trial

Kahtan Fadah, Gregory Piazza,

Watch time: 15m 37s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
ESC 22: Milvexian in Addition to Aspirin ＆ Clopidogrel for Secondary Stroke

Mukul Sharma,

Watch time: 6m 26s
ESC 22: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke

Ashkan Shoamanesh,

Watch time: 7m 9s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Alvaro Alonso , Antonio P Arenas de Larriva ,

Marc E Wolf , Michael G Hennerici ,

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)

Gheorghe-Andrei Dan , Adrian Catalin Buzea ,

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s

A John Camm ,

View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Nadzeya Kuzniatsova , Gregory YH Lip ,

Massimo Volpe , Giuliano Tocci , Francesca Giovannelli ,

W Kevin Tsai , Kathleen M Holohan , Kim Allan Williams ,

Wolfgang Herrmann , Rima Obeid ,

About

Several clinical and non-clinical risk factors for stroke in patients with atrial fibrillation have been identified, and clinically useful classification schemes have been developed to facilitate risk stratification in these patients.

Both a history of hypertension and systolic blood pressure >160 mmHg have been shown to be consistent independent risk factors for stroke, resulting in a twofold increase in stroke risk.

Media

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ACC 24 Late-Breaker Discussion: The AEGIS-II Trial

Harriette Van Spall, Michael C Gibson,

Watch time: 14m 7s
AHA ISC 24: ZODIAC: Zero Degree Head Positioning in Acute Stroke

Anne Alexandrov,

Watch time: 11m 16s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s

Klaus Witte, Matthew Reynolds, Paul Guyler, et al

Watch time: 1h 53s

Jayne Mudd, Jean-Claude Deharo, Rose Anne Kenny, et al

Watch time: 44m 22s

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)
ESC 2018: Comparison of simultaneous two-day external loop recording and Holter monitor recording for detection of atrial fibrillation in patients after acute ischemic stroke or transient ischemic attack

Michala Sejr,

Watch time: 6m 18s
AHA 2018: The Bridge Stroke trial

Julia Machline Carrion,

Watch time: 2m 56s
ACC 2021: The HOLIDAY Monitors Trial

Gregory Marcus ,

Watch time: 10m 38s

Articles

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist

,

Helmut Pürerfellner

,

Alex White

,

Richard Schilling

,

Published:

25 February 2021

Citation:

European Cardiovascular Review 2021;16(Suppl 1):1–6.

DOI:

https://doi.org/10.15420/ecr.2021.16.s1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 923
  • Downloads: Downloads 32

Atrial Fibrillation, Cognitive Decline and Dementia

Alvaro Alonso

,

Antonio P Arenas de Larriva

,

Citation:

European Cardiology Review 2016;11(1):49–53

DOI:

https://doi.org/10.15420/ecr.2016:13:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3158
  • Downloads: Downloads 6
  • Citations: 60

Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice

Gheorghe-Andrei Dan

,

Adrian Catalin Buzea

,

Citation:

European Cardiology Review 2015;10(2):76–8

DOI:

https://doi.org/10.15420/ecr.2015.10.2.76
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2106
  • Downloads: Downloads 10
  • Citations: 1

Foreword

Piotr Ponikowski

,

Citation:

European Cardiology 2012;8(3):150

DOI:

https://doi.org/10.15420/ecr.2012.8.3.150
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 168
  • Downloads: Downloads 1